Treatment Outcome of Patients with Buruli Ulcer Disease in Togo

Following introduction of antimycobacterial treatment of Buruli ulcer disease (BUD), several clinical studies evaluated treatment outcomes of BUD patients, in particular healing times, secondary lesions and functional limitations. Whereas recurrences were rarely observed, paradoxical reactions and f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS neglected tropical diseases 2015-10, Vol.9 (10), p.e0004170-e0004170
Hauptverfasser:	Beissner, Marcus, Arens, Nathalie, Wiedemann, Franz, Piten, Ebekalisaï, Kobara, Basile, Bauer, Malkin, Herbinger, Karl-Heinz, Badziklou, Kossi, Banla Kere, Abiba, Löscher, Thomas, Nitschke, Jörg, Bretzel, Gisela
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anti-Bacterial Agents - therapeutic use Buruli ulcer Buruli Ulcer - drug therapy Child Child, Preschool Clinical outcomes Development and progression Disease Documentation Edema Female Follow-Up Studies Funding Genetic aspects Humans Laboratories Male Medical records Middle Aged Patients Physical therapy Pilot Projects Recurrence Risk factors Skin diseases Streptomycin Studies Togo Treatment Outcome Wound Healing Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!